This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Zacks.com featured highlights include Amazon.com, Halozyme Therapeutics, Tenet Healthcare and Atmos Energy
by Zacks Equity Research
Amazon.com, Halozyme Therapeutics, Tenet Healthcare and Atmos Energy are part of the Zacks Screen of the Week article.
New Strong Buy Stocks for July 23rd
by Zacks Equity Research
KRO, TEF, STX, WGS and THC have been added to the Zacks Rank #1 (Strong Buy) List on July 23, 2024.
Best Value Stocks to Buy for July 23rd
by Zacks Equity Research
KBH, APOG and THC made it to the Zacks Rank #1 (Strong Buy) value stocks list on July 23, 2024.
Why Tenet Healthcare (THC) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
4 Stocks With Impressive Interest Coverage Ratio to Buy Now
by Sumit Singh
A company capable of generating earnings well above its interest expense can withstand financial hardship. AMZN, HALO, THC and ATO are sound enough to meet financial obligations.
Tenet Healthcare (THC) Ascends While Market Falls: Some Facts to Note
by Zacks Equity Research
Tenet Healthcare (THC) closed the most recent trading day at $133.27, moving +1.15% from the previous trading session.
Buying Tenet (THC) Pre-Q2 Earnings: A Prescription for Profits?
by Kaibalya Pravo Dey
Tenet Healthcare's (THC) second-quarter earnings are likely to have benefited from higher admissions, average length of stay and patient days.
4 Healthcare Stocks Poised to Beat Q2 Earnings Estimates
by Zacks Equity Research
Expanding aging population and the increasing demand for affordable health products are likely to have boosted the performance of healthcare stocks in Q2. CI, UHS, HCA & THC are potential outperformers.
Tenet Healthcare (THC) Suffers a Larger Drop Than the General Market: Key Insights
by Zacks Equity Research
In the latest trading session, Tenet Healthcare (THC) closed at $131.75, marking a -1.26% move from the previous day.
Investors Heavily Search Tenet Healthcare Corporation (THC): Here is What You Need to Know
by Zacks Equity Research
Tenet (THC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Tenet Healthcare (THC) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Tenet (THC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why Tenet Healthcare (THC) Gained But Lagged the Market Today
by Zacks Equity Research
Tenet Healthcare (THC) closed at $134.39 in the latest trading session, marking a +0.49% move from the prior day.
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Is Tenet Healthcare (THC) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Tenet Healthcare (THC) is a Top-Ranked Value Stock: Should You Buy?
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Encompass Health (EHC), Piedmont Expand Ties to Serve Georgia
by Zacks Equity Research
Encompass Health (EHC) expands its partnership with Piedmont to better serve Georgians with the Walton Rehabilitation Hospital.
Play Likely Earnings Beat With 5 Top-Ranked Stocks
by Sanghamitra Saha
Top-ranked stocks Chewy (CHWY), Wingstop (WING), Moderna (MRNA), Tenet Healthcare (THC) and Kinross Gold (KGC) are likely to beat on the bottom line in their upcoming releases.
Tenet Healthcare (THC) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the closing of the recent trading day, Tenet Healthcare (THC) stood at $129.27, denoting a -1.92% change from the preceding trading day.
Will Tenet (THC) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Tenet (THC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Zacks.com featured highlights include Tenet Healthcare, Leidos Holdings, Atmos Energy and Cabot
by Zacks Equity Research
Tenet Healthcare, Leidos Holdings, Atmos Energy and Cabot are part of the Zacks Screen of the Week article.
Here's Why You Should Retain Ensign Group (ENSG) Stock Now
by Zacks Equity Research
Ensign Group (ENSG) remains well-poised for growth on the back of solid segmental contributions, an expanding healthcare portfolio and sound cash reserves.
4 Stocks That Boast Remarkable Interest Coverage Ratio
by Sumit Singh
A company capable of generating earnings well above its interest expense can withstand financial hardship. THC, LDOS, ATO and CBT are sound enough to meet financial obligations.
Zacks.com featured highlights include Amkor Technology, Tenet Healthcare, Leidos and Maximus
by Zacks Equity Research
Amkor Technology, Tenet Healthcare, Leidos and Maximus are part of the Zacks Screen of the Week article.
Community Health (CYH) & Cost Plus Drugs Expand Collaboration
by Zacks Equity Research
Community Health (CYH) is now set to source drugs from the Cost Plus Drugs Marketplace under the new expanded partnership.